Tokyo, July 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062374) titled 'A study of how patients with eating disorders perceive foods' on July 28.

Study Type: Observational

Primary Sponsor: Institute - Department of NeuroPsychiatry, Yamaguchi University Hospital

Condition: Condition - Anorexia nervosa; Avoidant/restrictive food intake disorder Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - This study aims to compare subjective value ratings and subjective nutritional ratings obtained using a 90-item food image task between outpatients with anorexia nervosa and those with avoidant/restrictive food intake disorder. Associations with eating disorder symptoms, subjective state changes before and after the task, autistic traits, ADHD symptoms, clinical severity, and physical indices will also be explored. Basic objectives2 - Others

Eligibility: Age-lower limit - 11 years-old = Gender - Male and Female Key inclusion criteria - 1) Outpatients at the Department of Psychiatry and Neurology, Yamaguchi University Hospital, who are diagnosed with anorexia nervosa or avoidant/restrictive food intake disorder according to the DSM-5 criteria 2) Aged 11 to 50 years at the time of written informed consent 3) Individuals who have received sufficient explanation of the purpose and procedures of the study and have provided written informed consent 4) For minors, written consent from a legally acceptable representative and assent from the participant are required 5) No restriction on sex Key exclusion criteria - 1) Comorbid schizophrenia spectrum and other psychotic disorders, bipolar and related disorders, or depressive disorders according to the DSM-5 2) Suspected intellectual disability with an IQ below 70 and substantial difficulty understanding or completing the study tasks 3) Neurological disorders that may affect brain function, including epilepsy, cerebrovascular disease, sequelae of head injury, or neurodegenerative disease 4) Severe physical comorbidities, including hepatic dysfunction with AST or ALT greater than 100 IU/L or renal dysfunction with serum creatinine greater than 2.0 mg/dL 5) Continuous use of high doses of medications that may substantially affect cognitive function or responsiveness 6) Individuals considered unsuitable for participation by the principal investigator or a study investigator Target Size - 40

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 07 Month 13 Day Date of IRB - 2026 Year 07 Month 28 Day Anticipated trial start date - 2026 Year 07 Month 29 Day Last follow-up date - 2028 Year 06 Month 23 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071383

Disclaimer: Curated by HT Syndication.